Effects of ischemic pre- and postconditioning on cerebral glycogen synthase kinase-3 beta activity in a rat model of cerebral ischemia-reperfusion
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.0254-1416.2010.11.033
   		
        
        	
        		- VernacularTitle:缺血预处理和缺血后处理对大鼠脑缺血再灌注时糖原合酶激酶-3β活性的影响
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Bo ZHAO
			        		
			        		;
		        		
		        		
		        		
			        		Zhongyuan XIA
			        		
			        		;
		        		
		        		
		        		
			        		Wenwei GAO
			        		
			        		;
		        		
		        		
		        		
			        		Jiabao HOU
			        		
			        		;
		        		
		        		
		        		
			        		Yang WU
			        		
			        		;
		        		
		        		
		        		
			        		Hong GAO
			        		
			        		;
		        		
		        		
		        		
			        		Changjian WU
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Ischemic preconditioning;
			        		
			        		
			        		
				        		Glycogen synthase kinase 3;
			        		
			        		
			        		
				        		Reperfusion injury;
			        		
			        		
			        		
				        		Brain;
			        		
			        		
			        		
				        		Ischemic postconditioning
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Anesthesiology
	            		
	            		 2010;30(11):1391-1393
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To investigate the effects of ischemic pre- and postconditioning on cerebral glycogen synthase kinase-3 beta (GSK-3β) activity in a rat model of global cerebral ischemia-reperfusion (I/R).Methods Forty male Wistar rats weighing 200-230 g were randomly allocated into 4 groups (n =10 each) : Ⅰ group sham operation (group S); Ⅱ group I/R; Ⅲ group ischemic preconditioning (group IPR) and Ⅳ group ischemic postconditioning (group IPO). The animals were anesthetized with intraperitoneal 10% chloral hydrate 0.4 ml/100 g. Global cerebral ischemia was induced by four-vessel-occlusion in group Ⅱ , Ⅲ and Ⅳ. Bilateral vertebral arteries were cauterized and bilateral carotid arteries were occluded for 10 min. In group IPR cerebral ischemia was preceded by 3 cycles of 10 s ischemia followed by 30 s reperfusion. The group IPO received 3 cycles of 30 s reperfusion followed by 10 s ischemia at the end of 10 min cerebral ischemia. The animals were killed 2 days later. The brains were immediately removed for determination of neuronal apoptosis in the cortex (by TUNEL), the infarct size (by TTC), p-GSK-3β activity (by spectrum assay) and the expression of Bcl-2, Bax and Caspase-3 (by SP). Linear correlation of p-GSK-3β activity with the number of apoptotic neurons in the cortex and cerebral infarct size was analyzed. Results Cerebral I/R significantly increased the number of apoptotic neurons in the cortex and infarct size, decreased p-GSK-3β activity, down-regulated Bcl-2 expression and up-regulated Bax and Caspase-3 expression in group I/R as compared with group S. Ischemic pre- and postconditioning significantly attenuated these cerebral I/R-induced changes. The p-GSK-3β activity was negatively correlated with the number of apoptotic neurons in the cortex and cerebral infarct size. Conclusion Ischemic pre- and postconditioning reduces cerebral I/R injury through inhibiting the activity of GSK-3β.